Comorbidity and the treatment of principal anxiety disorders in a naturalistic sample.

نویسندگان

  • Lissa Davis
  • David H Barlow
  • Lisa Smith
چکیده

This study examined the impact of comorbidity on treatment outcome and the effects of cognitive behavioral therapy (CBT) for anxiety and depressive disorders on comorbid disorders in a naturalistic sample of 150 patients presenting to an anxiety disorders clinic. The following results were observed across principal (i.e., most severe) diagnoses. Patients with comorbid anxiety and depressive disorders presented for treatment with higher severity of their principal disorder than patients without comorbidity. However, the presence of comorbidity did not predict dropout or poor treatment response, and patients demonstrated significant improvement in their principal disorders regardless of comorbidity. The frequency of clinically severe and subclinical (i.e., not severe enough to meet diagnostic criteria) comorbid conditions decreased significantly over the course of treatment. The implication of these findings for the classification and treatment of emotional disorders is discussed.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

O4: Trans-Diagnostic CBT and Comorbidity in the Anxiety Disorders

Recent research from a number of clinical trials has shown that Transdiagnostic Cognitive-Behavioral Therapy is efficacious, having shown comparable effects on primary anxiety disorder diagnoses as traditional diagnosis-specific CBT, and highly economical for treatment providers. However, a majority of anxiety disorder patients present with two or more “comorbid” diagnoses at once. Given that T...

متن کامل

Duloxetine in Affective Disorders: a Naturalistic Study on Psychiatric and Medical Comorbidity, Use in Association and Tolerability Across Different Age Groups

OBJECTIVE Duloxetine, a selective serotonin and norepinephrine reuptake inhibitor (SNRI), is currently approved in many countries for the treatment of Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD). The present naturalistic study was aimed to investigate tolerability of Duloxetine in a sample of patients with affective disorders and psychiatric/medical comorbidity, compa...

متن کامل

P7: The Prevalence of Social Anxiety in Inpatients with Schizophrenia

Social anxiety is a frequent, disabling condition but often unrecognized feature in schizophrenia. The aim of this study was to describe the prevalence of social anxiety among inpatients with schizophrenia. Sixty inpatients with DSM-V schizophrenia were recruited from Niayesh psychiatric hospital in 2015 in Tehran, Iran. They were interviewed with the Anxiety Disorders section of the SCID for D...

متن کامل

Comorbidity of psychiatric disorders in attention deficit/hyperactivity disorder

Background and Objectives: Attention Deficit/Hyperactivity Disorder (ADHD) occurs concurrently with many psychiatric disorders. Considering lack of information about comorbid psychiatric disorders in Iranian children, this study was performed to evaluate the prevalence and pattern of psychiatric disorders comorbidity in the children with ADHD. Methods: In a cross sectional study, frequency of c...

متن کامل

اثربخشی درمان فراتشخیصی یکپارچه بر اختلالات اضطرابی و افسردگی همایند: طرح تک موردی

Background & aim: Anxiety and depression disorders have high rates of comorbidity. By emphasizing the central processes of psychopathology and targeting these common processes,   unified transdiagnostic treatment can be very effective in the treatment of comorbidity. Therefore, the present study was conducted to investigate the effect of Unified Transdiagnostic Treatment on Anxiety Di...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Behavior therapy

دوره 41 3  شماره 

صفحات  -

تاریخ انتشار 2010